COHEN & STEERS INC (CNS) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:CNS - US19247A1007 - Common Stock
64.58 USD
+0.63 (+0.99%)
64.58 USD
0 (0%)
We assign a fundamental rating of 5 out of 10 to CNS. CNS was compared to 237 industry peers in the Capital Markets industry. While CNS belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. While showing a medium growth rate, CNS is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
- In the past year CNS was profitable.
- CNS had a negative operating cash flow in the past year.
- CNS had positive earnings in each of the past 5 years.
- CNS had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
- With an excellent Return On Assets value of 20.48%, CNS belongs to the best of the industry, outperforming 97.47% of the companies in the same industry.
- The Return On Equity of CNS (29.83%) is better than 95.36% of its industry peers.
- CNS has a Return On Invested Capital of 24.42%. This is amongst the best in the industry. CNS outperforms 97.89% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 20.48% | ||
| ROE | 29.83% | ||
| ROIC | 24.42% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Profit Margin of CNS (29.73%) is better than 73.42% of its industry peers.
- In the last couple of years the Profit Margin of CNS has grown nicely.
- CNS has a better Operating Margin (33.83%) than 64.98% of its industry peers.
- CNS's Operating Margin has declined in the last couple of years.
- The Gross Margin of CNS (88.60%) is better than 92.83% of its industry peers.
- In the last couple of years the Gross Margin of CNS has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 33.83% | ||
| PM (TTM) | 29.73% | ||
| GM | 88.6% |
OM growth 3Y-4.66%
OM growth 5Y-2.01%
PM growth 3Y-3.48%
PM growth 5Y8.65%
GM growth 3Y0.67%
GM growth 5Y0.08%
2. Health
2.1 Basic Checks
- CNS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- CNS has an Altman-Z score of 9.07. This indicates that CNS is financially healthy and has little risk of bankruptcy at the moment.
- CNS's Altman-Z score of 9.07 is amongst the best of the industry. CNS outperforms 93.67% of its industry peers.
- CNS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 9.07 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
- A Current Ratio of 0.79 indicates that CNS may have some problems paying its short term obligations.
- CNS's Current ratio of 0.79 is on the low side compared to the rest of the industry. CNS is outperformed by 63.29% of its industry peers.
- A Quick Ratio of 0.79 indicates that CNS may have some problems paying its short term obligations.
- Looking at the Quick ratio, with a value of 0.79, CNS is doing worse than 62.87% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.79 | ||
| Quick Ratio | 0.79 |
3. Growth
3.1 Past
- The Earnings Per Share has been growing slightly by 5.80% over the past year.
- The Earnings Per Share has been growing slightly by 3.74% on average over the past years.
- CNS shows a small growth in Revenue. In the last year, the Revenue has grown by 7.04%.
- Measured over the past years, CNS shows a small growth in Revenue. The Revenue has been growing by 5.73% on average per year.
EPS 1Y (TTM)5.8%
EPS 3Y-5.81%
EPS 5Y3.74%
EPS Q2Q%3.85%
Revenue 1Y (TTM)7.04%
Revenue growth 3Y-0.12%
Revenue growth 5Y5.73%
Sales Q2Q%-5.55%
3.2 Future
- The Earnings Per Share is expected to grow by 8.66% on average over the next years. This is quite good.
- CNS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.70% yearly.
EPS Next Y8.49%
EPS Next 2Y8.3%
EPS Next 3Y8.22%
EPS Next 5Y8.66%
Revenue Next Year8.33%
Revenue Next 2Y7.78%
Revenue Next 3Y7.24%
Revenue Next 5Y6.7%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 20.83, the valuation of CNS can be described as rather expensive.
- Compared to the rest of the industry, the Price/Earnings ratio of CNS indicates a slightly more expensive valuation: CNS is more expensive than 60.34% of the companies listed in the same industry.
- CNS's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 28.39.
- CNS is valuated rather expensively with a Price/Forward Earnings ratio of 19.20.
- CNS's Price/Forward Earnings is on the same level as the industry average.
- When comparing the Price/Forward Earnings ratio of CNS to the average of the S&P500 Index (25.72), we can say CNS is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.83 | ||
| Fwd PE | 19.2 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CNS indicates a somewhat cheap valuation: CNS is cheaper than 79.32% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 16.12 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CNS does not grow enough to justify the current Price/Earnings ratio.
- The decent profitability rating of CNS may justify a higher PE ratio.
PEG (NY)2.45
PEG (5Y)5.57
EPS Next 2Y8.3%
EPS Next 3Y8.22%
5. Dividend
5.1 Amount
- CNS has a Yearly Dividend Yield of 3.88%. Purely for dividend investing, there may be better candidates out there.
- Compared to an average industry Dividend Yield of 5.88, CNS has a dividend in line with its industry peers.
- Compared to an average S&P500 Dividend Yield of 1.82, CNS pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.88% |
5.2 History
- The dividend of CNS decreases each year by -7.12%.
- CNS has been paying a dividend for at least 10 years, so it has a reliable track record.
- CNS has decreased its dividend in the last 3 years.
Dividend Growth(5Y)-7.12%
Div Incr Years2
Div Non Decr Years2
5.3 Sustainability
- CNS pays out 76.25% of its income as dividend. This is not a sustainable payout ratio.
DP76.25%
EPS Next 2Y8.3%
EPS Next 3Y8.22%
COHEN & STEERS INC / CNS FAQ
What is the ChartMill fundamental rating of COHEN & STEERS INC (CNS) stock?
ChartMill assigns a fundamental rating of 5 / 10 to CNS.
What is the valuation status for CNS stock?
ChartMill assigns a valuation rating of 3 / 10 to COHEN & STEERS INC (CNS). This can be considered as Overvalued.
Can you provide the profitability details for COHEN & STEERS INC?
COHEN & STEERS INC (CNS) has a profitability rating of 7 / 10.
Can you provide the financial health for CNS stock?
The financial health rating of COHEN & STEERS INC (CNS) is 5 / 10.
What is the expected EPS growth for COHEN & STEERS INC (CNS) stock?
The Earnings per Share (EPS) of COHEN & STEERS INC (CNS) is expected to grow by 8.49% in the next year.